25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GRF (Grifols) Stock Analysis
Buy, Hold or Sell?

Let's analyze Grifols together

I guess you are interested in Grifols S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Grifols’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Grifols’s Price Targets

I'm going to help you getting a better view of Grifols S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Grifols S.A.

I send you an email if I find something interesting about Grifols S.A..

1. Quick Overview

1.1. Quick analysis of Grifols (30 sec.)










1.2. What can you expect buying and holding a share of Grifols? (30 sec.)

How much money do you get?

How much money do you get?
€0.01
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
€12.66
Expected worth in 1 year
€16.34
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
€3.68
Return On Investment
34.9%

For what price can you sell your share?

Current Price per Share
€10.56
Expected price per share
€8.01 - €11.35
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Grifols (5 min.)




Live pricePrice per Share (EOD)
€10.56
Intrinsic Value Per Share
€0.61 - €10.23
Total Value Per Share
€13.27 - €22.89

2.2. Growth of Grifols (5 min.)




Is Grifols growing?

Current yearPrevious yearGrowGrow %
How rich?$10.1b$9.3b$747.4m7.4%

How much money is Grifols making?

Current yearPrevious yearGrowGrow %
Making money$184.8m$69.8m$114.9m62.2%
Net Profit Margin2.2%0.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Grifols (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Grifols?

Welcome investor! Grifols's management wants to use your money to grow the business. In return you get a share of Grifols.

First you should know what it really means to hold a share of Grifols. And how you can make/lose money.

Speculation

The Price per Share of Grifols is €10.56. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Grifols.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Grifols, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €12.66. Based on the TTM, the Book Value Change Per Share is €0.92 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Grifols.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps0.272.6%0.272.6%0.101.0%0.252.3%0.424.0%0.726.8%
Usd Book Value Change Per Share1.0810.3%1.0810.3%-0.86-8.1%0.262.4%0.636.0%1.039.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.131.2%0.272.5%
Usd Total Gains Per Share1.0810.3%1.0810.3%-0.86-8.1%0.262.4%0.767.2%1.3012.3%
Usd Price Per Share10.78-10.78-18.20-13.89-17.93-25.49-
Price to Earnings Ratio39.64-39.64-176.94-83.89-68.15-50.53-
Price-to-Total Gains Ratio9.94-9.94--21.26-4.01--480.16--219.12-
Price to Book Ratio0.72-0.72-1.32-0.97-1.35-3.01-
Price-to-Total Gains Ratio9.94-9.94--21.26-4.01--480.16--219.12-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share12.4327345
Number of shares80
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.13
Usd Book Value Change Per Share1.080.63
Usd Total Gains Per Share1.080.76
Gains per Quarter (80 shares)86.7360.61
Gains per Year (80 shares)346.94242.45
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1134633741201232
2169368483402474
3210391031124603716
4213861378166804958
531732172520710051200
632078207224812061442
742425241929014071684
842771276633116081926
953118311337318092168
1053464346041420102410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%7.03.00.070.0%15.05.00.075.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%18.00.02.090.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%16.04.00.080.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Grifols S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.9190.9190%-0.727+179%0.217+323%0.533+72%0.877+5%
Book Value Per Share--12.65912.6590%11.740+8%12.289+3%11.738+8%9.112+39%
Current Ratio--2.6562.6560%2.786-5%2.607+2%2.356+13%2.733-3%
Debt To Asset Ratio--0.5980.5980%0.628-5%0.611-2%0.594+1%0.611-2%
Debt To Equity Ratio--2.1752.1750%2.311-6%2.207-1%2.023+8%1.940+12%
Dividend Per Share--0.0010.0010%-+100%0.001+86%0.110-99%0.226-99%
Enterprise Value---5574378891.180-5574378891.1800%-2327477828.055-58%-4360190514.952-22%-329948439.127-94%6438426909.267-187%
Eps--0.2310.2310%0.087+164%0.208+11%0.360-36%0.612-62%
Ev To Ebitda Ratio---3.466-3.4660%-1.969-43%-3.295-5%-0.091-97%5.346-165%
Ev To Sales Ratio---0.773-0.7730%-0.353-54%-0.660-15%0.042-1961%1.554-150%
Free Cash Flow Per Share--0.9850.9850%-0.128+113%0.096+930%0.359+174%0.405+143%
Free Cash Flow To Equity Per Share---1.013-1.0130%0.146-796%-0.564-44%0.294-445%0.484-309%
Gross Profit Margin--1.0001.0000%0.911+10%-0.097+110%-0.129+113%0.435+130%
Intrinsic Value_10Y_max--10.234----------
Intrinsic Value_10Y_min--0.613----------
Intrinsic Value_1Y_max--0.540----------
Intrinsic Value_1Y_min--0.088----------
Intrinsic Value_3Y_max--1.992----------
Intrinsic Value_3Y_min--0.243----------
Intrinsic Value_5Y_max--3.890----------
Intrinsic Value_5Y_min--0.373----------
Market Cap4456162590.560-40%6219878108.8206219878108.8200%10495371171.945-41%8007244151.715-22%10363794960.873-40%14789145609.267-58%
Net Profit Margin--0.0220.0220%0.009+142%0.022+0%0.047-54%0.091-76%
Operating Margin--0.1830.1830%0.112+64%0.140+31%0.146+25%0.189-3%
Operating Ratio--0.8350.8350%0.879-5%0.866-4%0.860-3%0.815+2%
Pb Ratio0.834+13%0.7230.7230%1.316-45%0.968-25%1.348-46%3.014-76%
Pe Ratio45.734+13%39.63739.6370%176.943-78%83.887-53%68.145-42%50.528-22%
Price Per Share10.555+13%9.1489.1480%15.455-41%11.791-22%15.226-40%21.639-58%
Price To Free Cash Flow Ratio10.717+13%9.2899.2890%-120.447+1397%-43.355+567%-13.517+246%35.448-74%
Price To Total Gains Ratio11.467+13%9.9399.9390%-21.265+314%4.014+148%-480.159+4931%-219.121+2305%
Quick Ratio--0.8210.8210%0.679+21%0.737+11%0.908-10%1.326-38%
Return On Assets--0.0070.0070%0.003+165%0.007+11%0.015-51%0.033-78%
Return On Equity--0.0270.0270%0.010+162%0.024+13%0.047-43%0.100-73%
Total Gains Per Share--0.9200.9200%-0.727+179%0.218+322%0.643+43%1.104-17%
Usd Book Value--10138214747.50010138214747.5000%9390790081.500+8%9830381968.867+3%9400618243.520+8%7315919113.710+39%
Usd Book Value Change Per Share--1.0831.0830%-0.856+179%0.256+323%0.628+72%1.033+5%
Usd Book Value Per Share--14.91114.9110%13.828+8%14.475+3%13.826+8%10.732+39%
Usd Dividend Per Share--0.0020.0020%-+100%0.001+86%0.129-99%0.267-99%
Usd Enterprise Value---6566060895.921-6566060895.9210%-2741536133.666-58%-5135868407.562-22%-388646266.448-94%7583823056.426-187%
Usd Eps--0.2720.2720%0.103+164%0.245+11%0.424-36%0.721-62%
Usd Free Cash Flow--788757177.000788757177.0000%-102638672.300+113%76982047.133+925%288757237.820+173%325946367.780+142%
Usd Free Cash Flow Per Share--1.1601.1600%-0.151+113%0.113+930%0.423+174%0.477+143%
Usd Free Cash Flow To Equity Per Share---1.194-1.1940%0.172-796%-0.665-44%0.346-445%0.570-309%
Usd Market Cap5248913915.421-40%7326394424.3797326394424.3790%12362497703.434-41%9431732886.305-22%12207514084.412-40%17420134613.156-58%
Usd Price Per Share12.433+13%10.77510.7750%18.204-41%13.889-22%17.934-40%25.489-58%
Usd Profit--184836068.000184836068.0000%69867138.500+165%166678346.867+11%308229809.460-40%503019368.040-63%
Usd Revenue--8495464757.8008495464757.8000%7764689708.300+9%7800967065.133+9%7100730329.560+20%6128538667.770+39%
Usd Total Gains Per Share--1.0841.0840%-0.856+179%0.257+322%0.758+43%1.300-17%
 EOD+2 -6MRQTTM+0 -0YOY+29 -113Y+30 -105Y+19 -2110Y+16 -24

3.3 Fundamental Score

Let's check the fundamental score of Grifols S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1545.734
Price to Book Ratio (EOD)Between0-10.834
Net Profit Margin (MRQ)Greater than00.022
Operating Margin (MRQ)Greater than00.183
Quick Ratio (MRQ)Greater than10.821
Current Ratio (MRQ)Greater than12.656
Debt to Asset Ratio (MRQ)Less than10.598
Debt to Equity Ratio (MRQ)Less than12.175
Return on Equity (MRQ)Greater than0.150.027
Return on Assets (MRQ)Greater than0.050.007
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Grifols S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.257
Ma 20Greater thanMa 5010.356
Ma 50Greater thanMa 1009.565
Ma 100Greater thanMa 2009.340
OpenGreater thanClose10.585
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Grifols S.A.

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factor VIII/von Willebrand factor and factor IX, clotting factors for the treatment of hemophilia A and von Willebrand's disease, as well as hemophilia B; antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to control surgical bleeding; and plasma exchange with albumin used to treat Alzheimer's disease. It also markets diagnostic testing equipment, reagents, and other equipment; offers biological products and manufacturing services; and manufactures and sells plasma to third parties. In addition, the company offers Yimmugo IDP, an immunology drug; Yimmugo PTI, a hematology drug; and Prolastin vials, a pulmonology drug. Further, it develops Xembify Pre-filled syringes, Gamunex Bags, and FlexBag; Xembify Biweekly dosing, Fibrinogen, and VISTASEAL; Prolastin-C AADT and Fostamatinib; Xembify " CLL, Albumina 20% and 5%, and Trimodulin; Alfa-1 AT 15%, GRF6019, GRF6021, Aßvac402, AKST4290, and AKST4290; GIGA 2339 and GIGA564; and recIG, Alfa-1 AT - in non-cystic fibrosis bronchiectasis, and OSIG that are in pre-clinical stage. It has collaboration agreements with Canadian Blood Services to supply grains of Immunoglobulin. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Fundamental data was last updated by Penke on 2025-06-18 04:58:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Grifols earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 2.2%Β means thatΒ €0.02 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Grifols S.A.:

  • The MRQ is 2.2%. The company is making a profit. +1
  • The TTM is 2.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.2%TTM2.2%0.0%
TTM2.2%YOY0.9%+1.3%
TTM2.2%5Y4.7%-2.5%
5Y4.7%10Y9.1%-4.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Grifols is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • 0.7% Return on Assets means thatΒ Grifols generatedΒ €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Grifols S.A.:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.7%0.0%
TTM0.7%YOY0.3%+0.5%
TTM0.7%5Y1.5%-0.7%
5Y1.5%10Y3.3%-1.8%
4.3.1.3. Return on Equity

Shows how efficient Grifols is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • 2.7% Return on Equity means Grifols generated €0.03Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Grifols S.A.:

  • The MRQ is 2.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.7%0.0%
TTM2.7%YOY1.0%+1.6%
TTM2.7%5Y4.7%-2.0%
5Y4.7%10Y10.0%-5.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Grifols S.A..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Grifols is operatingΒ .

  • Measures how much profit Grifols makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • An Operating Margin of 18.3%Β means the company generated €0.18 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Grifols S.A.:

  • The MRQ is 18.3%. The company is operating efficient. +1
  • The TTM is 18.3%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ18.3%TTM18.3%0.0%
TTM18.3%YOY11.2%+7.1%
TTM18.3%5Y14.6%+3.7%
5Y14.6%10Y18.9%-4.3%
4.3.2.2. Operating Ratio

Measures how efficient Grifols is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.83 means that the operating costs are €0.83 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Grifols S.A.:

  • The MRQ is 0.835. The company is less efficient in keeping operating costs low.
  • The TTM is 0.835. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.835TTM0.8350.000
TTM0.835YOY0.879-0.044
TTM0.8355Y0.860-0.025
5Y0.86010Y0.815+0.045
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Grifols S.A..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Grifols is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.66Β means the company has €2.66 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Grifols S.A.:

  • The MRQ is 2.656. The company is able to pay all its short-term debts. +1
  • The TTM is 2.656. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.656TTM2.6560.000
TTM2.656YOY2.786-0.130
TTM2.6565Y2.356+0.301
5Y2.35610Y2.733-0.377
4.4.3.2. Quick Ratio

Measures if Grifols is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.82Β means the company can pay off €0.82 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Grifols S.A.:

  • The MRQ is 0.821. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.821. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.821TTM0.8210.000
TTM0.821YOY0.679+0.141
TTM0.8215Y0.908-0.087
5Y0.90810Y1.326-0.419
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Grifols S.A..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of GrifolsΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Grifols to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.60Β means that Grifols assets areΒ financed with 59.8% credit (debt) and the remaining percentage (100% - 59.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Grifols S.A.:

  • The MRQ is 0.598. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.598. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.598TTM0.5980.000
TTM0.598YOY0.628-0.030
TTM0.5985Y0.594+0.004
5Y0.59410Y0.611-0.017
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Grifols is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 217.5% means that company has €2.18 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Grifols S.A.:

  • The MRQ is 2.175. The company is just not able to pay all its debts with equity.
  • The TTM is 2.175. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.175TTM2.1750.000
TTM2.175YOY2.311-0.136
TTM2.1755Y2.023+0.153
5Y2.02310Y1.940+0.083
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Grifols generates.

  • Above 15 is considered overpriced butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A PE ratio of 39.64 means the investor is paying €39.64Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Grifols S.A.:

  • The EOD is 45.734. Based on the earnings, the company is overpriced. -1
  • The MRQ is 39.637. Based on the earnings, the company is overpriced. -1
  • The TTM is 39.637. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD45.734MRQ39.637+6.096
MRQ39.637TTM39.6370.000
TTM39.637YOY176.943-137.306
TTM39.6375Y68.145-28.508
5Y68.14510Y50.528+17.617
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Grifols S.A.:

  • The EOD is 10.717. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 9.289. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 9.289. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.717MRQ9.289+1.429
MRQ9.289TTM9.2890.000
TTM9.289YOY-120.447+129.735
TTM9.2895Y-13.517+22.806
5Y-13.51710Y35.448-48.965
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Grifols is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.72 means the investor is paying €0.72Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Grifols S.A.:

  • The EOD is 0.834. Based on the equity, the company is cheap. +2
  • The MRQ is 0.723. Based on the equity, the company is cheap. +2
  • The TTM is 0.723. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.834MRQ0.723+0.111
MRQ0.723TTM0.7230.000
TTM0.723YOY1.316-0.594
TTM0.7235Y1.348-0.626
5Y1.34810Y3.014-1.666
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets21,405,241
Total Liabilities12,798,216
Total Stockholder Equity5,883,727
 As reported
Total Liabilities 12,798,216
Total Stockholder Equity+ 5,883,727
Total Assets = 21,405,241

Assets

Total Assets21,405,241
Total Current Assets5,727,542
Long-term Assets15,677,699
Total Current Assets
Cash And Cash Equivalents 979,780
Short-term Investments 24,179
Net Receivables 741,430
Inventory 3,560,098
Other Current Assets 430,645
Total Current Assets  (as reported)5,727,542
Total Current Assets  (calculated)5,736,132
+/- 8,590
Long-term Assets
Property Plant Equipment 4,310,150
Goodwill 7,403,056
Long Term Investments 528,972
Intangible Assets 2,926,132
Long-term Assets Other 167,716
Long-term Assets  (as reported)15,677,699
Long-term Assets  (calculated)15,336,026
+/- 341,673

Liabilities & Shareholders' Equity

Total Current Liabilities2,156,146
Long-term Liabilities10,642,070
Total Stockholder Equity5,883,727
Total Current Liabilities
Short-term Debt 639,661
Short Long Term Debt 523,127
Accounts payable 852,305
Other Current Liabilities 508,329
Total Current Liabilities  (as reported)2,156,146
Total Current Liabilities  (calculated)2,523,422
+/- 367,276
Long-term Liabilities
Long term Debt 8,421,113
Capital Lease Obligations 1,141,379
Long-term Liabilities Other 45,416
Long-term Liabilities  (as reported)10,642,070
Long-term Liabilities  (calculated)9,607,908
+/- 1,034,162
Total Stockholder Equity
Common Stock119,604
Retained Earnings 205,681
Accumulated Other Comprehensive Income 4,782,162
Other Stockholders Equity 776,280
Total Stockholder Equity (as reported)5,883,727
Total Stockholder Equity (calculated)5,883,727
+/-0
Other
Capital Stock119,604
Cash and Short Term Investments 1,003,959
Common Stock Shares Outstanding 679,917
Current Deferred Revenue70,865
Liabilities and Stockholders Equity 21,405,241
Net Debt 9,105,839
Net Invested Capital 14,827,967
Net Working Capital 3,571,396
Property Plant and Equipment Gross 6,950,825
Short Long Term Debt Total 10,085,619



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
821,683
913,674
939,569
1,180,239
1,657,177
1,888,982
5,807,718
5,627,474
5,841,036
8,449,749
9,601,715
10,129,772
10,920,264
12,477,046
15,542,611
15,274,776
19,233,835
21,533,977
21,441,054
21,405,241
21,405,24121,441,05421,533,97719,233,83515,274,77615,542,61112,477,04610,920,26410,129,7729,601,7158,449,7495,841,0365,627,4745,807,7181,888,9821,657,1771,180,239939,569913,674821,683
   > Total Current Assets 
436,294
473,294
495,527
626,600
1,004,578
1,144,082
1,929,215
1,934,564
2,139,660
2,913,122
3,089,472
3,122,514
2,945,316
3,483,251
5,362,184
3,164,954
5,510,280
4,653,587
6,451,905
5,727,542
5,727,5426,451,9054,653,5875,510,2803,164,9545,362,1843,483,2512,945,3163,122,5143,089,4722,913,1222,139,6601,934,5641,929,2151,144,0821,004,578626,600495,527473,294436,294
       Cash And Cash Equivalents 
22,856
26,883
5,690
6,368
249,372
239,649
340,586
473,327
708,777
1,079,146
1,142,500
895,009
886,521
1,033,792
741,982
579,647
655,493
547,979
529,577
979,780
979,780529,577547,979655,493579,647741,9821,033,792886,521895,0091,142,5001,079,146708,777473,327340,586239,649249,3726,3685,69026,88322,856
       Short-term Investments 
661
6,232
7,080
6,657
8,217
12,946
16,904
0
232
476
509
957
702
822
1,727,429
10,861
2,029,107
43,256
116,143
24,179
24,179116,14343,2562,029,10710,8611,727,429822702957509476232016,90412,9468,2176,6577,0806,232661
       Net Receivables 
158,724
188,868
200,472
231,806
252,630
282,994
528,595
441,788
462,655
608,328
477,803
528,518
385,265
401,573
470,495
504,200
495,476
754,820
810,980
741,430
741,430810,980754,820495,476504,200470,495401,573385,265528,518477,803608,328462,655441,788528,595282,994252,630231,806200,472188,868158,724
       Inventory 
249,545
235,475
270,659
373,098
484,462
527,865
1,030,341
998,644
946,913
1,194,057
1,431,391
1,642,931
1,629,293
1,949,360
2,342,590
2,002,281
2,259,354
3,201,357
3,459,277
3,560,098
3,560,0983,459,2773,201,3572,259,3542,002,2812,342,5901,949,3601,629,2931,642,9311,431,3911,194,057946,913998,6441,030,341527,865484,462373,098270,659235,475249,545
       Other Current Assets 
4,508
15,836
11,106
8,648
10,292
81,143
15,466
20,613
21,315
31,591
37,778
56,056
44,237
98,526
90,379
51,750
64,079
149,431
1,535,928
430,645
430,6451,535,928149,43164,07951,75090,37998,52644,23756,05637,77831,59121,31520,61315,46681,14310,2928,64811,10615,8364,508
   > Long-term Assets 
385,389
440,380
444,042
553,639
652,599
744,900
3,878,503
3,692,910
3,701,376
5,536,627
6,512,243
7,007,258
7,974,948
8,993,795
10,180,427
12,109,822
13,723,555
16,880,390
14,989,149
15,677,699
15,677,69914,989,14916,880,39013,723,55512,109,82210,180,4278,993,7957,974,9487,007,2586,512,2435,536,6273,701,3763,692,9103,878,503744,900652,599553,639444,042440,380385,389
       Property Plant Equipment 
186,621
184,993
201,332
301,009
371,705
434,131
775,869
810,107
840,238
1,147,782
1,644,402
1,809,852
1,760,053
1,951,983
2,863,403
3,002,803
3,343,154
4,168,489
4,192,363
4,310,150
4,310,1504,192,3634,168,4893,343,1543,002,8032,863,4031,951,9831,760,0531,809,8521,644,4021,147,782840,238810,107775,869434,131371,705301,009201,332184,993186,621
       Goodwill 
117,115
150,820
150,243
158,567
174,000
189,448
1,895,101
1,869,899
1,829,141
3,174,732
3,532,359
3,643,995
4,590,498
5,209,230
5,507,063
5,332,271
6,228,901
7,011,909
6,802,127
7,403,056
7,403,0566,802,1277,011,9096,228,9015,332,2715,507,0635,209,2304,590,4983,643,9953,532,3593,174,7321,829,1411,869,8991,895,101189,448174,000158,567150,243150,820117,115
       Long Term Investments 
0
0
0
0
0
0
0
0
39,130
58,651
78,137
232,421
259,063
228,820
143,984
2,067,177
2,359,975
2,548,892
565,105
528,972
528,972565,1052,548,8922,359,9752,067,177143,984228,820259,063232,42178,13758,65139,13000000000
       Intangible Assets 
48,718
60,850
57,223
57,756
69,385
78,299
1,008,307
969,095
946,435
1,068,361
1,161,572
1,195,302
1,269,342
1,385,537
1,433,534
1,557,650
1,636,950
2,949,147
2,832,196
2,926,132
2,926,1322,832,1962,949,1471,636,9501,557,6501,433,5341,385,5371,269,3421,195,3021,161,5721,068,361946,435969,0951,008,30778,29969,38557,75657,22360,85048,718
       Other Assets 
0
0
0
0
0
0
0
0
46,432
132,363
140,910
156,107
328,337
505,430
564,251
812,555
882,614
174,923
-13,616
0
0-13,616174,923882,614812,555564,251505,430328,337156,107140,910132,36346,43200000000
> Total Liabilities 
765,736
545,322
555,403
698,960
1,078,649
1,181,592
4,142,724
3,746,733
3,733,832
5,786,861
6,300,325
6,401,794
7,286,299
7,780,442
8,696,843
8,554,721
11,086,800
13,076,433
13,468,569
12,798,216
12,798,21613,468,56913,076,43311,086,8008,554,7218,696,8437,780,4427,286,2996,401,7946,300,3255,786,8613,733,8323,746,7334,142,7241,181,5921,078,649698,960555,403545,322765,736
   > Total Current Liabilities 
252,405
282,764
316,576
317,538
299,043
423,126
646,077
592,865
715,296
1,079,711
1,053,006
1,071,763
977,987
1,257,321
1,366,558
1,335,138
3,474,312
1,955,847
2,315,604
2,156,146
2,156,1462,315,6041,955,8473,474,3121,335,1381,366,5581,257,321977,9871,071,7631,053,0061,079,711715,296592,865646,077423,126299,043317,538316,576282,764252,405
       Short-term Debt 
96,998
136,736
183,992
151,710
113,991
194,915
150,224
192,003
251,389
165,860
186,797
203,944
133,067
10,427
320,802
319,571
2,394,182
681,273
897,915
639,661
639,661897,915681,2732,394,182319,571320,80210,427133,067203,944186,797165,860251,389192,003150,224194,915113,991151,710183,992136,73696,998
       Short Long Term Debt 
0
0
0
0
0
0
0
0
2,730,711
154,567
188,073
200,085
129,122
264,851
276,397
276,929
2,345,615
578,917
790,814
523,127
523,127790,814578,9172,345,615276,929276,397264,851129,122200,085188,073154,5672,730,71100000000
       Accounts payable 
69,623
67,236
76,934
99,215
120,909
160,678
280,722
228,405
273,621
439,631
409,986
461,073
423,096
561,883
581,882
601,618
628,992
731,918
813,114
852,305
852,305813,114731,918628,992601,618581,882561,883423,096461,073409,986439,631273,621228,405280,722160,678120,90999,21576,93467,23669,623
       Other Current Liabilities 
85,784
78,792
51,880
50,251
60,885
63,361
210,440
157,462
167,219
339,602
400,563
358,037
372,259
632,316
399,597
389,969
407,599
470,016
550,859
508,329
508,329550,859470,016407,599389,969399,597632,316372,259358,037400,563339,602167,219157,462210,44063,36160,88550,25151,88078,79285,784
   > Long-term Liabilities 
513,331
262,558
238,827
381,422
779,606
758,466
3,496,647
3,153,868
3,018,536
4,707,150
5,247,319
5,330,031
6,308,312
6,523,121
7,330,285
7,219,583
7,612,488
11,120,586
11,152,965
10,642,070
10,642,07011,152,96511,120,5867,612,4887,219,5837,330,2856,523,1216,308,3125,330,0315,247,3194,707,1503,018,5363,153,8683,496,647758,466779,606381,422238,827262,558513,331
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,885,043
7,179,483
9,068,852
0
0
009,068,8527,179,4836,885,043000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
536,531
601,091
675,473
648,935
430,134
502,613
544,198
627,755
682,364
2,051,734
0
0
002,051,734682,364627,755544,198502,613430,134648,935675,473601,091536,53100000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
45,262
45,137
70,620
232,345
287,205
331,808
575,515
633,240
1,622,641
0
0
001,622,641633,240575,515331,808287,205232,34570,62045,13745,262000000000
> Total Stockholder Equity
55,826
367,944
383,185
480,029
566,371
693,040
1,662,507
1,876,768
2,101,262
2,658,123
3,296,203
3,721,481
3,629,079
4,225,554
4,822,119
5,108,392
6,096,643
6,129,938
5,827,166
5,883,727
5,883,7275,827,1666,129,9386,096,6435,108,3924,822,1194,225,5543,629,0793,721,4813,296,2032,658,1232,101,2621,876,7681,662,507693,040566,371480,029383,185367,94455,826
   Common Stock
70,169
106,532
106,532
106,532
0
0
117,882
1,008,237
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
119,604
119,604
119,604119,6041,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,008,237117,88200106,532106,532106,53270,169
   Retained Earnings 
25,556
45,394
0
0
147,972
115,513
50,307
256,686
276,796
384,309
412,530
422,548
539,714
459,895
488,318
618,546
182,803
208,279
79,356
205,681
205,68179,356208,279182,803618,546488,318459,895539,714422,548412,530384,309276,796256,68650,307115,513147,9720045,39425,556
   Accumulated Other Comprehensive Income 
-39,899
216,018
85,940
163,054
224,650
352,871
627,074
614,905
794,134
1,312,734
1,911,916
2,337,311
2,121,455
2,790,768
3,353,053
3,503,248
5,047,697
5,053,547
4,890,267
4,782,162
4,782,1624,890,2675,053,5475,047,6973,503,2483,353,0532,790,7682,121,4552,337,3111,911,9161,312,734794,134614,905627,074352,871224,650163,05485,940216,018-39,899
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
910,728
910,728
910,728
0
0
00910,728910,728910,728000000000000000
   Treasury Stock00000000000000000000



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,212,382
Cost of Revenue-4,364,683
Gross Profit2,847,6992,847,699
 
Operating Income (+$)
Gross Profit2,847,699
Operating Expense-1,655,684
Operating Income1,192,0151,192,015
 
Operating Expense (+$)
Research Development384,036
Selling General Administrative1,255,291
Selling And Marketing Expenses0
Operating Expense1,655,6841,639,327
 
Net Interest Income (+$)
Interest Income44,423
Interest Expense-714,765
Other Finance Cost-30,782
Net Interest Income-701,124
 
Pretax Income (+$)
Operating Income1,192,015
Net Interest Income-701,124
Other Non-Operating Income Expenses0
Income Before Tax (EBT)443,9961,940,034
EBIT - interestExpense = 604,754
388,110
871,685
Interest Expense714,765
Earnings Before Interest and Taxes (EBIT)1,319,5191,158,761
Earnings Before Interest and Taxes (EBITDA)1,608,263
 
After tax Income (+$)
Income Before Tax443,996
Tax Provision-231,190
Net Income From Continuing Ops212,806212,806
Net Income156,920
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,020,367
Total Other Income/Expenses Net-748,019701,124
 

Technical Analysis of Grifols
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Grifols. The general trend of Grifols is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Grifols's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Grifols Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Grifols S.A..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 10.74 < 11.27 < 11.35.

The bearish price targets are: 9.866 > 9.368 > 8.01.

Know someone who trades $GRF? Share this with them.πŸ‘‡

Grifols S.A. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Grifols S.A.. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Grifols S.A. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Grifols S.A.. The current macd is 0.23407987.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Grifols price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Grifols. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Grifols price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Grifols S.A. Daily Moving Average Convergence/Divergence (MACD) ChartGrifols S.A. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Grifols S.A.. The current adx is 22.80.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Grifols shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Grifols S.A. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Grifols S.A.. The current sar is 9.9176928.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Grifols S.A. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Grifols S.A.. The current rsi is 62.26. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Grifols S.A. Daily Relative Strength Index (RSI) ChartGrifols S.A. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Grifols S.A.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Grifols price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Grifols S.A. Daily Stochastic Oscillator ChartGrifols S.A. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Grifols S.A.. The current cci is 73.76.

Grifols S.A. Daily Commodity Channel Index (CCI) ChartGrifols S.A. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Grifols S.A.. The current cmo is 26.07.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Grifols S.A. Daily Chande Momentum Oscillator (CMO) ChartGrifols S.A. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Grifols S.A.. The current willr is -23.78318584.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Grifols is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Grifols S.A. Daily Williams %R ChartGrifols S.A. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Grifols S.A..

Grifols S.A. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Grifols S.A.. The current atr is 0.26369802.

Grifols S.A. Daily Average True Range (ATR) ChartGrifols S.A. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Grifols S.A.. The current obv is -42,314,486.

Grifols S.A. Daily On-Balance Volume (OBV) ChartGrifols S.A. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Grifols S.A.. The current mfi is 53.98.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Grifols S.A. Daily Money Flow Index (MFI) ChartGrifols S.A. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Grifols S.A..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Grifols S.A. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Grifols S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.257
Ma 20Greater thanMa 5010.356
Ma 50Greater thanMa 1009.565
Ma 100Greater thanMa 2009.340
OpenGreater thanClose10.585
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Grifols with someone you think should read this too:
  • Are you bullish or bearish on Grifols? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Grifols? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Grifols S.A.

I send you an email if I find something interesting about Grifols S.A..


Comments

How you think about this?

Leave a comment

Stay informed about Grifols S.A..

Receive notifications about Grifols S.A. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.